Pfizer-biontech | search
Click here to view Pfizer-biontech news from 60+ newspapers.
Bookmark or Share- Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full U.S. FDA ...The Pfizer-BioNTech COVID-19 Vaccine has received EUA from FDA to: prevent COVID-19 in individuals 12 years of age and older, and; provide a third dose to individuals 12 years of age and older who have been determined to have certain kinds of immunocompromise
- Pfizer and BioNTech Provide Update on mRNA-based Combination Vaccine ...NEW YORK & MAINZ, Germany--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced top-line results from their Phase 3 clinical trial to evaluate the companies’ combined mRNA vaccine candidate against influenza and COVID-19 in healthy individuals 18-64 years of age. The ...
- 2024-2025 Formula Pfizer-BioNTech COVID-19 Vaccine At A GlancePfizer-BioNTech COVID-19 Vaccine At-A-Glance Guidance below summarizes basic storage, preparation, scheduling, administration, and dosage for all 2024–25 Pfizer-BioNTech COVID-19 vaccine products. Distributed in: Ages: 6 months through 4 years Multi-dose vial. yellow cap and yellow label. Ages: 5 through 11 years Single-dose vial
- Pfizer COVID-19 Vaccine Summary | Vaccines & Immunizations | CDCPfizer-BioNTech COVID-19 Vaccine is indicated for individuals 5 through 11 years of age (via a 10mcg / 0.3mL single-dose vial presentation) and for individuals 6 months through 4 years of age (via a 3mcg / 0.3mL multi-dose vial (3 doses per vial) presentation).
- FACT SHEET FOR RECIPIENTS AND CAREGIVERS ABOUT PFIZER-BIONTECH COVID-19 ...The Pfizer-BioNTech COVID-19 Vaccine is a vaccine for use in individuals 6 months through 11 years of age to prevent COVID-19. The FDA has authorized the emergency
More
